Patients receiving tirzepatide 15 mg lost an average of 12.4 kg (about 13.1% of baseline weight), roughly double the 6.2 kg (6.7%) seen with semaglutide
Lining up certain labs before your first dose helps rule out hidden problems and shows where your health stands right now
Our IV Wellness Therapies are administered by licensed professionals in a comfortable, spa-like environment
As with other incretin receptor agonists, the most frequently reported side effects of retatrutide in clinical trials were gastrointestinal in nature , and were most pronounced during the dose escalation phase
Factors that predict better outcomes include higher starting BMI, adherence to dietary recommendations, regular physical activity, proper dose titration, and consistent weekly administration
Potential side effects to GLP-1 agonists: understanding their safety and tolerability